ALZPROTECT
LIVE

Serial Number

79292735

Owner

ALZPROTECT

Attorney

John J. O'Malley

Filing Date

Jul 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ALZPROTECT Trademark

Serial Number: 79292735 • Registration: 6443519

ALZPROTECT is a trademark filed by ALZPROTECT on July 17, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ALZPROTECT

Parc Eurasanté - le Galenis

Entity Type: 99

Trademark Details

Filing Date

July 17, 2020

Registration Date

August 10, 2021

Published for Opposition

May 25, 2021

Goods & Services

Pharmaceutical products for the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease, amyloidopathies, tauopathies and synucleopathies; medicines; active ingredients of medicines for the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease, amyloidopathies, tauopathies and synucleopathies; diagnostic agents for medical use; diagnostic preparations for medical use; diagnostic biomarker reagents for medical purposes; diagnostic agents for veterinary use; diagnostic preparations for veterinary use; dietetic foods adapted for medical use; dietetic foodstuffs adapted for veterinary use; food supplements; chemical preparations for medical use namely for the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease, amyloidopathies, tauopathies and synucleopathies ; chemical preparations for pharmaceutical use namely for the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease, amyloidopathies, tauopathies and synucleopathies; medicinal herbs; herbal teas for medicinal purposes; food supplements consisting of vitamins; vitamin supplements; vitamin preparations; dietetic preparations adapted for medical purposes and food supplements; dietetic food supplements based primarily on vitamins adapted for medical purposes; dietetic food preparations adapted for medical purpose; medicated food supplements; nutritional and food supplements; vitamin and mineral supplements; vitamin preparations; nutritional supplements consisting primarily of vitamins or minerals for medical use; vitamins and minerals; nutraceuticals for use as a dietary supplement for therapeutic use; nutraceutical preparations for use as a dietary supplement for therapeutic or medical use; nutraceutical products used as dietary supplements

Diagnostic preparations for science or research; diagnostic products for science or research; diagnostic reagents for science or research; active chemical ingredients for use in the manufacture of medicines for Alzheimer's disease; active synthetic organic chemical products and/or reagents used in the manufacture of medicaments, especially for the treatment of neurodegenerative diseases such as Alzheimer's disease, amyloidopathies, tauopathies and synucleopathies; synthetic organic chemical products and/or reagents used in the manufacture of veterinary products; synthetic organic chemicals for use in industry and science; chemical reagents other than for medical or veterinary use; vitamins for the manufacture of food supplements

Medical diagnostic services for diagnostic and treatment purposes provided by medical laboratories; medical services; hospital services; alternative medicine services; providing nutrition information

Evaluations, estimates and research in the scientific and technological fields of therapeutic treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease, amyloidopathies, tauopathies and synucleopathies, provided by engineers or researchers; research and product development in the field of diagnostic products and preparations; research and development of pharmaceutical products and preparations; research and development of medicines; medicine discovery services in the nature of development of pharmaceutical preparations; engineering services in the form of technical evaluations concerning design for quality control concerning design of new pharmaceutical products; scientific research; technical research in the field of pharmaceutical studies; research and development of new products for third parties; conducting of technical project studies namely, technological research in the field of medical instruments

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 6, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 18, 2022 FICS
FINAL DISPOSITION PROCESSED
Jan 18, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 10, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 10, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 25, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 25, 2021 PUBO
NOTIFICATION PROCESSED BY IB
May 23, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 5, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 5, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 5, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 21, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 20, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 20, 2021 TROA
REFUSAL PROCESSED BY IB
Dec 13, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 23, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 23, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 5, 2020 RFCR
NON-FINAL ACTION WRITTEN
Nov 4, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 2, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 8, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 3, 2020 REPR